top

Coline Pinese

Coline Pinese

Associate professor, Faculty of Pharmacy, University of Montpellier

Coline has been working at the chemistry/biology interface since her doctorate CIFRE obtained in 2014. Her objective was to design hybrid collagen/PLA based copolymer biomaterials for ligament regeneration. She then continued her work at the interface by studying bioactive surfaces functionalized by peptides (antibacterial, osteointegration, wound healing…). Then she became involved into spinal cord regeneration through an association mRNA or siRNA/ nanofibers at Nayang Technological University, Singapore. She finally joined the DBA team as an Associate Professor to develop polymer/peptide hybrid nanomaterials.

Contact:

tel: +33 4 11 75 97 10

coline.pinese@umontpellier.fr

5 recent publications:

  • W.Ong, C. Pinese, SY Chew, Scaffold-mediated  Sequential  Drug/Gene  Delivery  to  Promote  Nerve  Regeneration  and Remyelination following Traumatic Nerve Injuries, Advanced Drug Delivery Reviews (2018) (IF=17.28)
  • Pinese, JQ. Lin, U. Milbreta, Y. Wang, KW. Leong, SY Chew, Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing. Acta Biomater. 76, 164–177 (2018). (IF=6.38)
  • Gangolphe, S. Déjean, A. Bethry, S. Hunger, C. Pinese, X. Garric, F. Bossard, B. Nottelet, Degradable multi(aryl-azide) star copolymer as universal photo-crosslinker for elastomeric scaffolds, Materials Today Chemistry 12, (2019) 209-221 (IF=NA)

Biomimicking Fiber Scaffold as an Effective In Vitro and In Vivo MicroRNA Screening Platform for Directing Tissue Regeneration

This is custom heading element

Adv. Sci. 6, 1800808 (2019)

Na Zhang, Ulla Milbreta, Jiah Shin Chin, Coline Pinese, Junquan Lin, Hitomi Shirahama, Wei Jiang, Hang Liu, Ruifa Mi, Ahmet Hoke, Wutian Wu and Sing Yian Chew

ABSTRACT

MicroRNAs effectively modulate protein expression and cellular response. Unfortunately, the lack of robust nonviral delivery platforms has limited the therapeutic application of microRNAs. Additionally, there is a shortage of drug‐screening platforms that are directly translatable from in vitro to in vivo. Here, a fiber substrate that provides nonviral delivery of microRNAs for in vitro and in vivo microRNA screening is introduced. As a proof of concept, difficult‐to‐transfect primary neurons are targeted and the efficacy of this system is evaluated in a rat spinal cord injury model. With this platform, enhanced gene‐silencing is achieved in neurons as compared to conventional bolus delivery (p < 0.05). Thereafter, four well‐recognized microRNAs (miR‐21, miR‐222, miR‐132, and miR‐431) and their cocktails are screened systematically. Regardless of age and origin of the neurons, similar trends are observed. Next, this fiber substrate is translated into a 3D system for direct in vivo microRNA screening. Robust nerve ingrowth is observed as early as two weeks after scaffold implantation. Nerve regeneration in response to the microRNA cocktails is similar to in vitro experiments. Altogether, the potential of the fiber platform is demonstrated in providing effective microRNA screening and direct translation into in vivo applications.

Scaffold-Mediated Sustained, Non-viral Delivery of miR-219/miR-338 Promotes CNS Remyelination

This is custom heading element

Mol. Ther. 27, 411–423 (2019)

Ulla Milbreta, Junquan Lin, Coline Pinese, William Ong, Jiah Shin Chin, Hitomi Shirahama, Ruifa Mi, Anna Williams, Marie E. Bechler, Jun Wang, Charles french-Constant, Ahmet Hoke and  Sing Yian Chew

ABSTRACT

The loss of oligodendrocytes (OLs) and subsequently myelin sheaths following injuries or pathologies in the CNS leads to debilitating functional deficits. Unfortunately, effective methods of remyelination remain limited. Here, we present a scaffolding system that enables sustained non-viral delivery of microRNAs (miRs) to direct OL differentiation, maturation, and myelination. We show that miR-219/miR-338 promoted primary rat OL differentiation and myelination in vitro. Using spinal cord injury as a proof-of-concept, we further demonstrate that miR-219/miR-338 could also be delivered non-virally in vivo using an aligned fiber-hydrogel scaffold to enhance remyelination after a hemi-incision injury at C5 level of Sprague-Dawley rats. Specifically, miR-219/miR-338 mimics were incorporated as complexes with the carrier, TransIT-TKO (TKO), together with neurotrophin-3 (NT-3) within hybrid scaffolds that comprised poly(caprolactone-co-ethyl ethylene phosphate) (PCLEEP)-aligned fibers and collagen hydrogel. After 1, 2, and 4 weeks post-treatment, animals that received NT-3 and miR-219/miR-338 treatment preserved a higher number of Olig2+ oligodendroglial lineage cells as compared with those treated with NT-3 and negative scrambled miRs (Neg miRs; p < 0.001). Additionally, miR-219/miR-338 increased the rate and extent of differentiation of OLs. At the host-implant interface, more compact myelin sheaths were observed when animals received miR-219/miR-338. Similarly within the scaffolds, miR-219/miR-338 samples contained significantly more myelin basic protein (MBP) signals (p < 0.01) and higher myelination index (p < 0.05) than Neg miR samples. These findings highlight the potential of this platform to promote remyelination within the CNS.

Scaffold-mediated sequential drug/gene delivery to promote nerve regeneration and remyelination following traumatic nerve injuries

This is custom heading element

Adv. Drug Deliv. Rev. (2019)

Ong, W., Pinese, C. & Chew, S. Y.

Review on sequential drug delivery in SCI

ABSTRACT

Stem cells combined with biodegradable injectable scaffolds releasing growth factors hold great promises in regenerative medicine, particularly in the treatment of neurological disorders. We here integrated human marrow-isolated adult multilineage-inducible (MIAMI) stem cells and pharmacologically active microcarriers (PAMs) into an injectable non-toxic silanized-hydroxypropyl methylcellulose (Si-HPMC) hydrogel. The goal is to obtain an injectable non-toxic cell and growth factor delivery device. It should direct the survival and/or neuronal differentiation of the grafted cells, to safely transplant them in the central nervous system, and enhance their tissue repair properties. A model protein was used to optimize the nanoprecipitation conditions of the neuroprotective brain-derived neurotrophic factor (BDNF). BDNF nanoprecipitate was encapsulated in fibronectin-coated (FN) PAMs and the in vitro release profile evaluated. It showed a prolonged, bi-phasic, release of bioactive BDNF, without burst effect. We demonstrated that PAMs and the Si-HPMC hydrogel increased the expression of neural/neuronal differentiation markers of MIAMI cells after 1 week. Moreover, the 3D environment (PAMs or hydrogel) increased MIAMI cells secretion of growth factors (b-NGF, SCF, HGF, LIF, P1GF-1, SDF-1 alpha, VEGF-A & D) and chemokines (MIP-la & RANTES, IL-8). These results show that PAMs delivering BDNF combined with Si-HPMC hydrogel represent a useful novel local delivery tool in the context of neurological disorders. It not only provides neuroprotective BDNF but also bone marrow-derived stem cells that benefit from that environment by displaying neural commitment and an improved neuroprotective/reparative secretome. It provides preliminary evidence of a promising pro-angiogenic, neuroprotective and axonal growth-promoting device for the nervous system. Statement of Significance Combinatorial tissue engineering strategies for the central nervous system are scarce. We developed and characterized a novel injectable non-toxic stem cell and protein delivery system providing regenerative cues for central nervous system disorders. BDNF, a neurotrophic factor with a wide-range effect, was nanoprecipitated to maintain its structure and released in a sustained manner from novel polymeric microcarriers. The combinatorial 3D support, provided by fibronectin-microcarriers and the hydrogel, to the mesenchymal stem cells guided the cells towards a neuronal differentiation and enhanced their tissue repair properties by promoting growth factors and cytokine secretion. The long-term release of physiological doses of bioactive BDNF, combined to the enhanced secretion of tissue repair factors from the stem cells, constitute a promising therapeutic approach.

Degradable multi(aryl-azide) star copolymer as universal photo-crosslinker for elastomeric scaffolds

This is custom heading element

Mater. Today Chem. 12, 209-221, (2019)

Gangolphe L., Déjean S., Bethry A., Hunger S., Pinese C., Garric X., Bossard F., Nottelet B.

ABSTRACT

Degradable elastomers with elastic properties close to those of soft-tissues are necessary for tissue-engineering. Most degradable elastomers developed so far are based on functional low molecular weight pre-polymers that are combined with molecular crosslinkers to yield the elastomeric 3D networks. To overcome this limitation, we present in this work the concept of star-shaped macromolecular multi(aryl-azide) photo-crosslinker that has the ability to efficiently crosslink any polymer containing C-H bonds independently of its molecular weight and without the need for pre-functionalization. This concept of universal crosslinking agent is illustrated with a star-shaped block copolymer composed of an 8-arm poly(ethylene glycol) core and poly(lactide) side arms functionalized with aryl-azide moieties (PEG8arm-PLA-fN3). It was selected due to its macromolecular nature that allows for an easy processing of electrospun photo-crosslinked scaffolds while making it possible to adapt its chemical nature with the one of the polymer matrix. A parameter study is first carried out on PEG8arm-PLA-fN3 / PLA-Pluronic®-PLA films to evaluate the impact of the polymers molecular weight, PEG/PLA ratios, and UV irradiation conditions on the crosslinking efficiency. This study confirms that high crosslinking efficiencies can be obtained with PEG8arm-PLA-fN3 (60%) compared to commercially availabe bis(aryl-azide) photo-crosslinker (below 15%). Optimal conditions are then used to yield electrospun microfibers (1-2 µm) crosslinked with PEG8arm-PLA-fN3 resulting in biocompatible and highly elastomeric scaffolds (ε_y>100%) compared to uncrosslinked scaffolds(ε_y<10%). In addition, we show that the degradation rate can be controlled over time depending on the blend content of PEG8arm-PLA-fN3. Taken together, these results demonstrate the potential of macromolecular multi(aryl-azide) photo-crosslinkers to develop original degradable elastomeric scaffolds for soft-tissue reconstruction.